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:ةصلاخلا 
فدهلا.ةفلتخملا لمحلا لحارم يف ةرركتم تاطاقسإ نهيدل يتلالا  ءاسنلل  مدلا لصم يف نيلوسنلأا ىوتسم عافترا نيب ةقلاعلا داجيا : 
ةيجهنملام ةسارد : نم ةرتفلل فرشلاا فجنلا ةظفاحم يف  لافطلأاو ةيئاسنلل يميلعتلا ءارهزلا ىفشتسم يف تيرجا ةرطيسلا تانيع عون ن
ةنس لولأا نيرشت نم لولأا ىتحو طابش نم لولأا2014  نغلب ءاسنلا نم هعومجمل160  بحس ةساردلا نمضتتو .نيتعومجم ىلع هأرمأ
إ نهيدل يتلالا ءاسنلا كلت نم مد تانيع يأ اهيدل سيل ريخلأا رهشلا يف لماوح ءاسن نم ىرخأ تانيعو )تلااحلا ةعومجم( ةرركتم تاطاقس
  ةرارح ةجردب تنزخ تانيعلا ذخأ دعب, هقباس ةرركتم تاطاقسإ20-   .ازيللأا ةقيرطب نيلوسنلأا ةبسن سايق مت كلذ دعب مث ةيوئم ةجرد 
جئاتنلاءاسنلا دنع يلاع نيلوسنلاا ىوتسم نا دجو :  يف يونعم قرف كانهف :لمحلا نم لولاا ثلثلا يف ةصاخ ةرركتم تاطاقسا نهيدل يتلالا
 ثلاثلا ثلثلاو لولاا ثلثلا نيب يونعم قرف كانه سيل امنيب هنم لولاا ثلثلا عم ةنراقملاب لمحلا نم يناثلا ثلثلا يف نيلوسنلاا ىوتسمم .هن
 ثلثلا يف ةرركتم تاطاقسا نهيدل يتلالا ءاسنلا ددع.لمحلا نم لحارم ريغ يف تاطاقسا نهيدل يتلالا ءاسنلا نم رثكا لمحلا نم لولاا 
: جاتنتسلاا تاطاقسإ نهيدل سيل يتلالا ءاسنلا عم ةنراقملاب ةقباس ةرركتم تاطاقسإ نهيدل يتلالا ءاسنلل مدلا يف نيلوسنلأا ةبسن عافترإ ظحول
. ةقباس هرركتم 
تايصوتلا تسم سايقب  نيتثحابلا يصوت: ةزفحملا لماوعلا مادختساب اضيا يصوتو , ةرركتم تاطاقسا نهيدل يتلالا ءاسنلل نيلوسنلاا ىو
.لمحلا لبق ةيمويلا ةيضايرلا نيرامتلاو مسجلا نزو ليلقتو نيلوسنلأل 
 
Abstract 
Aim of study; To find the relationship between rise plasma  insulin level in women with recurrent pregnancy 
loss at different gestational age. 
Methodology :A case control study done in Al Zahraa teaching  hospital in Al-Najaf city from the first of 
February to the first of October in 2014 of 160 women divided in two groups .  We estimate fasting serum 
insulin hormone in samples of women with recurrent pregnancy loss at different trimester(as a case group) 
and healthy pregnant women at the end of 3rd trimester( as a control group ). The estimation of recurrent 
pregnancy loss in women at different trimester is associated with endocrine abnormalities where serum  
insulin level  increase in a different way compared with normal healthy pregnant women. 
Results: We found the level of insulin hormone was high in women with  recurrent pregnancy loss especially 
in the 1st trimester ,therefore there is significant difference in insulin level in 2nd trimester compared to the 
1st trimester while it is not significant between 1st and 3rd trimester, the number of women who lost their 
pregnancy during the 1st trimester was higher than those lossing during other trimesters. 
Conclusion :Current study showed that, in women with  recurrent pregnancy loss, fasting insulin level is 
high compared with normal healthy pregnant women.  
Recommendations: We recommend that measuring fasting insulin level  is usefull in all women with 
recurrent pregnancy loss The use of insulin sensitizing agent (metformin) and decrease body weight with 
regular daily exercise before embarking in pregnancy  
  
Keywords;   insulin ,pregnancy loss. 
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INTRODUCTION 
              Recurrent pregnancy loss is a distinct disorder defined by two or more failed clinical  
pregnancies. A fetal  loss up to 24 completed weeks of gestation is defined as a miscarriage. 
Intra uterine death: It is a clinical term for death of baby in the uterus, during pregnancy 
and before birth. The term used for pregnancy losses that happen after the 24th week of 
gestation(1). 
           Incidence: Recurrent pregnancy loss is the most common complication of 
pregnancy. Approximately 50% of all conceptions are lost, the majority of which is 
unrecognized clinically. Farther more,15-25%(almost one in 6)of all clinically recognized 
pregnancies end in pregnancy loss(1). 
         Causes  of early pregnancy loss:  It is important to identify and focus on specific risk 
factors or  causes of recurrent pregnancy loss as evidence  shows that  greatest  reductions 
in recurrent loss pregnancy in the past have occurred with target strategies(2)1- 
chromosomal abnormalities: This is an abnormality with the genetic material of an 
embryo and usually occurs when the chromosomes from the egg and the sperm fail to line 
up correctly this can result from flawed genetic material  (translocation) from the mother 
or father that does not necessarily affect the mother or father’ s health but can prevent an 
embryo from developing correctly, because the baby only inherits half of each parents 
genes there is still chance of creating a healthy baby if the defect gets bypasses or 
spontaneously corrects itself when the embryo is created. 2-Uterine abnormalities: 
Abnormalities of the uterus are well established  as a cause  of pregnancy loss . these 
abnormalities may be the result of trauma ( as Asher man’ s syndrome) or abnormal 
development . the developmental anomalies include the  septate , bicornuate unicorn ate 
and didelphys uterus.3- Endocrine causes: like hypo or hyperthyroidism a very common 
endocrine issue affecting many women symptoms can be very subtle and can present with 
recurrent miscarriages only. Other causes of endocrine like diabetes  And 
hyperprolactinemia ,It has been reported that hyperprolactinemia is a cause of recurrent 
miscarriage and that treatment with bromocriptine which suppresses prolactin secretion by 
the anterior pituitary, significantly reduces the miscarriage rate(3)   .4- Luteal phase 
abnormalities:Insufficient progesterone secretion by the corpus luteal or placenta, also 
termed a luteal phase defect, has been suggested to cause miscarriage. Deficient 
progesterone production,however,may be the consequence rather than the cause of early 
pregnancy loss(4).5- Immu nological disorders Antiphospholipid syndrome is an 
autoimmune disorder defined by the presense of characteristic clinical features 
antiphosphlipid antibodies, the most common and serious complications of this disorder 
are venous and arterial thrombosis, the increased thrombotic potential in women with 
antiphospholipid syndrome is associated with recurrent pregnancy loss after 10 weeks 
gestation(5).6- bacterial infection: Any sever infection that leads to the bacteremia or 
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viremia can cause an early sporadic miscarriage, recent study has reported that positive 
immunoglobulin G(IgG) serology for CLAMYDIA TRCHOMATIS  is associated with 
early but  not late miscarriage, the authors suggest that even in the absence of detectable 
organism, previous CLAMYDIA infection increases the miscarriage risk possibly by 
triggering chronic inflammation(6).7- Thrombophilia  
The pregnancy is a hypercoagulable state secondary to an increase in the levels of 
some coagulation factors,  and a decrease in the levels of anticoagulant proteins, and an 
increase in fibrinolysis. Thrombophilic defect is an abnormality in the coagulation system 
that predisposes individual to thrombosis, the presumed hypothesis is that some cases of 
recurrent miscarriage and later pregnancy complications are caused by an exaggerated 
hemostatic response during pregnancy, leading to thrombosis of the uteroplacental 
vasculature and sub sequent fetal demise(7).8- Environmental:Smoking , alcohol and 
recreational drugs have all been associated with increased miscarriage rates ,so cessation 
of such substances is recommended.9- Un explained causes.Causes of late pregnancy 
loss:There are several factors associated with fetal loss  some of these may have a direct 
link to fetal loss (for example abruption or cord event) and others have indirect cause like 
obesity ,so the most common causes of late pregnancy loss are the following(1,2). 
 (I) - maternal age; In< 20  years may be associated with   preterm birth, fetal growth 
restriction ,pre-eclampsia. In>40    years   is a risk for Diabetes, chromosomal 
abnormalities, preterm birth, pre-eclampsia,growth restriction, multiple pregnancies. 
(II)- hypertensive  disorder such; Chronic hypertension, mild and sever pregnancy 
induced hypertension. 
(III)-Endocrine and autoimmune disease;   A-Insulin dependent diabetes and non-
insulin dependent diabetes may be associated with  Pre-eclampsia, thromboembolic 
disease, macrosomia, fetal growth restriction;B-S L E ( systemic lupus erthromatosus) is a 
risk for superimposed PET, abruption, FGR(fetal growth restriction) , renal dysfunction, 
thromboembolic events.C-Thyroid disorders is a risk for; preterm birth ,neuro 
developmental problems in offspring of hypothyroid mothers.  
D-Thrombophilia is a risk for thromboembolic disease ,PET  and abruption. 
E-Cholestasis of pregnancy may be associated with sudden unexpected fetal death. 
 (IV) - Marked obesity (BMI>3Okg/m²) may be associated with thromboembolic 
disease ,PET  and abruption. thromboembolic disease ,PET  and abruption. 
 (V)- Multiple gestation (twin or triplet) is a recognized cause of;preterm birth, fetal 
growth restriction, anti- partum hemorrhage, congenital abnormalities, twin to twin 
infusion (if mono – chorionic twins), cerebral palsy. (VI)- Ethnicity ; Black  women have 
been shown to have high risk of pre- eclampsia, diabetes and sickle cell disease. 
  (VII)- Smoking cigarettes  > 10 is a risk for preterm birth, fetal growth restriction,  
cognitive impairment in offspring. 
Pathophysiology of insulin resistance ;Insulin hormone it is an endocrine hormone 
that secreted in to the maternal and to lesser extent in to the fetal blood stream were they 
act  as placental signals and nourish the fetus, making them possible candidates for the 
endocrine control of the placenta. Decrease insulin sensitivity or increase insulin resistance 
is defined as the decrease biological response of nutrient to a given concentrion of insulin 
at the target tissue,e.g. liver, muscle or a adipose tissue. Obesity is the most common risk 
factor related to decrease insulin sensitivity.Insulin resistance is often associated with a 
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hypercoagulable state(impaired fibrinolysis) and increased inflammatory cytokine levels 
insulin resistance has been demonstrated to increase expression of plasminogen activator 
inhipter-1(PAI-1).plasminogen activator inhibiter-1(PAI-1) activity is known elevate 
levels of serum insulin and it induces a hypofibrinolytic state.This creates a thrombotic 
milieu at the maternofetal interface with high risk of miscarriage insulin resistance  is 
known to play a critical role in the ovarian androgen excess and  therefore might promote 
miscarriage by increasing circulating testosterone concentration.  Insulin resistance 
/hyperinsulinemia is frequently associated with 40-50 % of women having poly cystic 
ovary syndrome especially obese women(8).Furthermore, obese women with polycystic 
ovary syndrome are more likely indicative of insulin resistance than lean women with or 
without polycystic ovary syndrome .Insulin resistance/ hyperinsulinemia correlate with 
implantation disturbances and cause infertility in polycystic ovary syndrome. However, 
few potential mechanisms of insulin resistant may contribute to abortion.. 
First: insulin resistant may cause excessive transport of glucose to the fetal 
environment  leading to an increased loss in the first pregnancy. 
second:Hyper insulinemia can elevate plasminogen activator inhipter-1(PAI-1) 
concentrations, which can lead to thrombotic induction and placental  insufficiency(9). 
Third:Increased insulin concentrations are responsible for decreased concentrations 
of serum glycogen and insulin growth factor binding protein 1(IGFBP-1), which have been 
observed in the first trimester of poly cystic ovary syndrome patients. Decrease 
concentrations of these proteins suggest deficient endometrial development during the peri-
implantation period(10). 
Association of  insulin  resistance  and obesity;Insulin resistance (IR) is a 
physiological condition in which cells fail to respond to the normal actions of the  insulin 
hormone.The body produces insulin, but the cells in the body become resistant to insulin 
and are unable to use it as effectively, leading to hyperglycemia. Beta cells in the pancreas 
subsequently increase their production of insulin, further contributing to 
hyperinsulinemia.It is well known that insulin resistance commonly coexists with obesity. 
However, causal links between insulin resistance, obesity, and dietary factors are complex 
and controversial. It is possible that one of them arises first, and tends to cause the other; 
or that insulin resistance and excess body weight might arise independently as a 
consequence of a third factor, but end up reinforcing each other. Some population groups 
might be genetically predisposed to one or the other .Another possible explanation is that 
both insulin resistance and obesity often have the same cause, a systematic overeating, 
which has the potential to lead to insulin resistance and obesity due to repeated 
administration of excess levels of glucose, which stimulate insulin secretion; excess levels 
of fructose, which raise triglyceride levels in the bloodstream; and fats, which can be easily 
absorbed by the adipose cells and tend to end up as fatty tissue in a hyper caloric diet(11).The 
most common type of insulin hormon resistance is associated with over weight and obesity 
in a condition known as the metabolic syndrome.Insulin resistance often progresses to full 
type 2diabetes mellitus(T2DM)or latent autoimmune diabetes of adults(12,13).This is often 
seen when hyperglycemia develop after a meal. 
             Pancreatic B-cells are unable to produce sufficient insulin to maintain normal  
blood sugar level(euglycemia) in the face of insulin resistance .The in ability of the B-cells 
to produce sufficient  insulin in a condition of hyperglycemia is what characterizes the 
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transition from insulin resistance to T2diabetes mellitus(14).Insulin itself leads to a kind of 
insulin of insulin resistance ,every time acell is exposed to insulin,the production of 
GLUT4(type four glucose receptors)on the cells membrane decrease somewhat(15).In the 
presence of a higher than usual  level of insulin (generally caused by insulin resistance),this 
down regulation act as akind of positive feedback,increasing the need for insulin .Exercise 
reverses this process in muscle tissue(16).but if it is left unchecked,it can contribute to 
insulin resistance.Insulin resistance is often found in people with viseral adiposity (i.e.,a 
high degree of fatty tissue within the abdomen as adistinct from subcutaneous adiposity or 
fat between the skin and the muscle wall,especially elsewhere on the body ,such as hips 
and thighs),hypertension,hyperglycemia and dyslipidemia involving elevated 
triglycerides,small dense low density lipoprotein particles,and decreased HDL(high 
density lipoprotein cholesterol levels.Insulin resistance is also often associated with 
ahypercoagulable state(impaired fibrinolysis) and increased inflammatory cytokine levels. 
      PCOS and Insulin Resistance:Polycystic ovary syndrome (PCOS) patients are known 
to have a high incidence of insulin resistance and glucose intolerance and tend to be at high 
risk of hypertension, diabetes mellitus and cardiovascular disease. Insulin resistance, 
probably via hyperinsulinemia, results in a general augmentation of steroid genesis and LH 
release in PCOS.The profound insulin resistance and defects in insulin secretion, together 
with obesity, explain the substantially increased prevalence of glucose intolerance in 
PCOS. A number of obese PCOS patients display a particular metabolic pattern including 
an atherogenic lipid profile (dyslipidemia), glucose intolerance and an increased fasting 
insulin level, which is known to be closely linked with an insulin resistant state. 
(Approximately 75% of patients with PCOS are insulin resistant. 
 
PATIANTS AND METHODS 
          This is a prospective case control study done in Al Zahraa teaching hospital in Al-
Najaf city from the first of February to the first of October during year 2014 and its consist 
of 160 pregnant women enrolled in this study and divided into two groups :the first group 
was 80 pregnant women with pregnancy loss at different trimester as a(case group).  
patients with poly cystic ovary syndrome and patients with diabetes are excluded after done 
for them oral glucose tolerance test and the second group was 80 healthy pregnant women 
at the of third trimester with no previous history of pregnancy loss as(a control group)  .All 
patients are agreed to participate in this study by verbal consent. and then complete history 
from each patient was recorded on specially prepared data sheets including ;( number of 
pregnancy loss and time of pregnancy loss ,age,parity,gravidity and  time of previous 
pregnancy loss).A fasting venous blood sample was aspirated from each patient at time of  
admision and from the control group. 
          Blood samples was collected in a tube chilled into ice then centerifuged, clear plasma 
was separated and plasma insulin hormone was assayed by Enzyme Linked Immuno 
Sorbent Assay (ELISA) technique. 
Using insulin level kit. Then to evaluate serum insulin level in both groups.where the 
normal range of serum insulin level is 2-25µuI/ml. 
 
STATISTICAL ANALYSIS 
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         Statistical analysis was done by using SPSS (statistical package for social sciences) 
version 20, in which we use independent sample T-test,ANOVA(analysis of variance) 
and person correlation coefficient for numerical data .We set up p value < 0.05 as 
significant. 
 
RESULTS: 
          The results of this study consist of 160 women, 80 cases and 80 controls. The age, 
BMI and insulin level of these women had been shown in table 1 and 2. 
 
Table (1) Mean and standard deviation of controls 
 Minimum Maximum Mean Std. Deviation 
Age/years 22.00 35.00 28.8205 3.12773 
Insulin 
level(µIu/ml) 
10.770 16.883 12.72923 1.482723 
BMI(kg/m²) 19.00 32.00 26.13 2.89 
 
table 1;show that the mean age of women was 28.8±3.12years and the mean insulin 
level was 12.72±1.4. The body mass index of control group was 26.13±2.89 Kg/m2 
 
Table(2) Mean and standard deviation of cases 
 Minimum Maximum Mean Std. Deviation 
Age/years 15.00 35.00 27.8462 4.36737 
Insulin level(µIu/ml) 9.787 54.213 26.80717 10.267065 
BMI(kg/m²) 19.00 25.00 22.67 2.45 
table 2 ;show that the mean age of women was 27.84 yearsand the mean insulin level 
was 26.8±10.26. The body mass index of cases group was 22.67±2.45 Kg/m2 
 
 
 
 
Table(3) Comparison between cases and controls in different variables. 
Variables Cases(n=80) Controls(n=80) P value 
Mean ±SD Mean ±SD 
Age/years 27.84±4.36 28.82±3.12 0.679 
Insulin 
level(µIu/ml) 
26.8±10.267 12.729±1.482 <0.001 
BMI(kg/m²) 22.67±2.45 26.13±2.89  0.031 
table 3 ;show that there were significant difference in insulin level and BMI between 
cases and controls(as we show in this tabel the mean of insulin level in case group more 
than the upper normal limit compared with control group where the insulin level within 
normal range)while there were no significant difference between the two groups in age. 
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Figure(1) Patients distribution according to their time of loss 
The highest percentage of recurrent pregnancy loss was found among women in their 
first trimester(45%) whereas it was (33.7%) for women in the second trimester. However 
it was much less in women during their third trimester (21.3%). 
 
Table(4) Comparison between three trimesters in patient group. 
Estimated 
variables 
Trimester 
P value 
First (n=36) Second(n=27) Third(n=17) 
Age/years 27.86±3.64 28.44±5.53 26.81±3.76 0.632 
Insulin 
level(µIu/ml) 
31.182±7.1 *22.158±9.82 25.05±13.39 0.021 
BMI(kg/m²) 23.21±2.2 22.34±2.7 23.54±1.9 0.899 
table 4;show that there were significant difference in insulin level in the second 
trimester compared to the first trimester while it is non-significant between the first and 
third trimester. Also non-significant difference between groups regarding age and BMI. 
 
 
DISCUSSION 
      Recurrent pregnancy loss is one of the most frustrating and difficult areas in 
reproductive medicine because the etiology is often unknown and there are a few evidence 
based diagnostic and treatment strategies. Dysregulation of insulin metabolism and /or in 
the placenta may be implicated in the pathogenesis of various disorders during pregnancy 
such as recurrent miscarriage, gestational diabetes,intrautrine growth retardation and pre-
eclampsia. 
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      Patients in this study were classified as having recurrent pregnancy loss which was 
associated with endocrine abnormalities ,this abnormalities obvious in their  insulin 
level,with significantly higher level than the level found in the control group(table3) and 
this finding agree with corina-alina Ispasoiu and Iverson CLstudy(17,18).Also in this study 
we aimed to identify the age factor and its relation with recurrent pregnancy loss,as we 
know that incidence of recurrent pregnancy loss increase with increase maternal age but in 
our study we take the range of maternal age between 15years and 35years,therefore we 
noticed there is no significant difference in age between cases and control group and this 
is consistence with study ofcorina-alinaIspasoiu study(17). 
             Another  remarkable factor introduce in this study the effect of the body mass index 
which is associated with metabolic glucose intolerance,type2diabetesmellitus and 
dyslipidemia and non-metabolic disorders.However, more than its total amount, the 
distribution of adipose tissue throughout the body is a better predictor of the risk to the 
development of those disorders .Fat accumulation in the abdominal area and in non-adipose 
tissue is associated with an increase risk to develop metabolic and non-metabolic 
derangements. So in our study the body mass index introduce was up to 25 in case group 
and we notice a significant difference between case group and control group and this is 
inconsistence withrayah S Baban,et al(19)study. In addition we found that percentage of 
pregnancy loss increase in 1st trimester compared with 2nd trimester and the latter is more 
compared with the loss in the 3rd trimester and this consistence with Craigl,et alstudy (9). 
There is a significant difference in insulin level in the 2nd trimester compared with the 1st 
trimester while there is no significant difference between 1st and 3rd trimester and this go 
with other study.Lowering of insulin level with insulin sensitivity agents(metformin) 
enhances uterine vascularity and reduces uterine vascular resistanceand decrease rates of 
early pregnancy loss in a series of small studies(20). 
 
CONCLUSION 
          Current study showed that, in women with  recurrent pregnancy loss, fasting 
insulin is high compared with normal healthy pregnant women. 
 
RECOMMENDATION 
         We recommend that measring fasting insulin level usefull in all women with recurrent 
pregnancy loss. Also because of most pregnancy losses occurred during the first trimester, 
it is highly recommended that insulin hormone evaluation tests are provided as early as 
possible were pregnancy occur. 
           Insulin elevation during pregnancy may serve as markers for detecting and 
monitoring pregnancy complications specially if cases of recurrent pregnancy loss (RpL) 
have no specific medical cause for pregnancy loss.The use of insulin sensitizing agent 
(metformin) and decrease body weight with regular daily exercise before embarking in 
pregnancy ,also from recommendation. furthermore comprehensive studies are needed in 
the future. 
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